HUMA Humacyte Inc
Company Analysis
Latest News
🔴 Humacyte Inc is trading 5% down today after recent dilutive stock offering
Humacyte Inc is trading 5% down at $0.88 as investors continue to react to the company's recently priced public offering of common stock. • The stock has been...
🔴 Humacyte Inc is trading 6.0% down today after recent $50M public offering
• Humacyte Inc. shares are down 6.0% today, continuing a multi-day slide that began in early June. • The decline is influenced by the $50 million public...
🟢 Humacyte Inc is trading 6.3% up today with no clear company-specific catalyst found
Humacyte Inc is trading at $1.03 (+6.31%) in pre-market action despite a lack of company-specific headlines, earnings releases, or regulatory updates. • The...
🔴 Humacyte Inc is trading 6.7% down today as investors take profits and react to its recent $50M public offering
Humacyte Inc is trading at $0.96, down 6.7% today as investors continue to take profits following a recent public offering. • The company recently completed a...
Humacyte to Seek FDA Dialysis Approval, Following Positive Phase 3 Results
Humacyte (Nasdaq: HUMA) plans to file a supplemental Biologics License Application (sBLA) with the FDA in the second half of 2026. The submission seeks to...